MD Anderson launches cell therapy research institute

Houston-based University of Texas MD Anderson Cancer Center has launched the Institute for Cell Therapy Discovery & Innovation. Research at the institute will focus on immunology and cell engineering with the purpose of creating new treatments for cancer and autoimmune disease.

Advertisement

The institute will be led by Katy Rezvani, MD, PhD, with the support of an internal advisory council, a pipeline review committee and an executive advisory board, according to a Nov. 8 news release from the cancer center. 

MD Anderson was able to establish the institute with philanthropic and institutional aid of more than $80 million, the release said.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.